Physician profile
Mark A Borsch
NPI 1447288667
$16,257.48
in general payments reported to CMS, 2019-2025
48 companies · $2,692 in 2025
The $2,692 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,532 · 2020: $1,898 · 2021: $2,308 · 2022: $2,962 · 2023: $2,104 · 2024: $2,762 · 2025: $2,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,557.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,716.14 | 2019-2025 | Xience Skypoint, Dragonfly Opstar, Ultreon |
| Novartis Pharmaceuticals Corporation | $2,776.95 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,048.33 | 2019-2025 | Lifevest |
| Cardiovascular Systems INC. | $1,013.20 | 2019-2021 | |
| Abiomed | $945.05 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $797.67 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $549.93 | 2019-2023 | Jardiance |
| Philips North America LLC | $531.96 | 2019-2025 | Coronary Other, (Br3) Coronary Other, (Bq9) Coronary Ivus |
| Amgen INC. | $393.96 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $372.62 | 2019-2025 | Wainua, Farxiga |
| Medtronic, INC. | $253.78 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Abre |
| Cvrx, INC. | $222.43 | 2024-2025 | Barostim Neo System |
| Pfizer INC. | $213.65 | 2019-2024 | |
| Esperion Therapeutics, INC. | $197.91 | 2021-2023 | Nexletol |
| Atricure, INC. | $188.01 | 2022-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $153.80 | 2019-2024 | |
| Shockwave Medical, INC | $145.34 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiva Medical, INC. | $131.41 | 2024-2025 | Optowire, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Penumbra, INC. | $120.23 | 2025 | Penumbra System |
| Elutia, INC. | $116.09 | 2021-2023 | |
| Portola Pharmaceuticals, LLC | $113.80 | 2019 | |
| Boston Scientific Corporation | $107.36 | 2019-2025 | Eluvia |
| Daiichi Sankyo INC. | $103.31 | 2021-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $100.30 | 2022-2025 | |
| Amarin Pharma, INC. | $91.73 | 2019-2020 | |
| Teleflex LLC | $85.58 | 2022-2024 | Vascband, Turnpike |
| Merck Sharp & Dohme LLC | $68.19 | 2024-2025 | Verquvo, Capvaxive |
| Medtronic Vascular, INC. | $65.35 | 2019 | |
| Angiodynamics, INC. | $59.10 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $51.95 | 2024-2025 | Camzyos, Eliquis |
| Lexicon Pharmaceuticals, INC. | $46.69 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $45.41 | 2024-2025 | Opsumit, Uptravi, Opsynvi |
| Endologix LLC | $41.26 | 2019 | |
| Inari Medical, INC. | $39.65 | 2022 | |
| Surmodics, INC. | $38.38 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy |
| Convatec INC. | $36.41 | 2022-2023 | |
| Cook Medical LLC | $33.46 | 2020-2025 | Zilver Ptx |
| Siemens Medical Solutions USA, INC. | $31.31 | 2024 | Artis Icono Floor |
| Novo Nordisk INC | $30.56 | 2024 | Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $29.65 | 2024 | Amvuttra |
| Astellas Pharma US INC | $27.80 | 2019 | |
| Gilead Sciences, INC. | $22.94 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $21.90 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $20.55 | 2023 | Zio Xt Patch |
| Baxter Healthcare | $18.04 | 2022 | |
| Asahi Intecc USA, INC. | $15.27 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $11.62 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Borsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.